Skip to main content
. 2011 Nov 30;13(2):121–127. doi: 10.1007/s10194-011-0405-6

Table 2.

Characteristics of the study population (n = 465)

Variable All patients (n = 465) Antimigraine drug users (n = 365) No antimigraine drug users (n = 100) p value
Age (years), mean (SD) 43.5 (10.9) 43.8 (10.9) 42.3 (11.0) 0.210
Gender female, n (%) 433 (93.1) 338 (92.6) 95 (95.0) 0.402
CGI, mean (SD) 2.4 (2.3) 2.4 (2.3) 2.7 (2.2) 0.150
RI, mean (SD) 17.6 (10.5) 17.7 (10.3) 17.5 (11.3) 0.861
Depression, n (%) 307 (66.0) 240 (65.8) 67 (67.0) 0.816
Diagnosis of migraine, n (%) 233 (50.1) 133 (36.4) 100 (100)a <0.001

CGI care gap index, RI risk index, SD standard deviation

aPatients who neither used antimigraine drugs nor had migraine diagnosis were not included in the study